UNSPSC 51434802: Benclonidine

This classification denotes an antihypertensive agent with the molecular formula C16H13Cl2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1999398A3P, chemically known as 4,5-dihydro-1-benzoyl-n-(2,6-dichlorophenyl)-1h-imidazol-2-amine but generally known as benclonidine, which bears US NIH Compound Identifier 68774. European Medicines Agency schedules Benclonidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05704MIG.

UNSPSC 51434802 Benclonidine, a Commodity code, encompasses pharmaceutical products supplied to state and local emergency medical services, health and human services agencies, and multistate cooperative purchasing alliances. State and local governments procure under this code specific medications for emergency response and clinical care — including advanced life support drugs, generic pharmaceuticals, and over-the-counter products distributed through established wholesaler networks and direct-to-manufacturer relationships. Issuing bodies include city fire rescue departments, state health agencies, and cooperative purchasing consortia serving multiple jurisdictions. The City of Tampa Fire Rescue, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the mix of municipal, state-agency, and multistate-cooperative buyers active in this space.

Recent opportunities span Florida, Texas, and Minnesota. The City of Tampa issued IFB 26P00188 (due April 8, 2026) for advanced life support medications including labetalol, epinephrine, adenosine, and diltiazem to supply Tampa Fire Rescue in Hillsborough County, with an estimated contract value of $40,000 and a one-year initial term plus renewal options; this solicitation carried a Small Local Business Enterprise 5 percent bid discount capped at $10,000. The Texas Health and Human Services Commission posted RFI HHS0017013 (due April 3, 2026) seeking vendor capability information on direct-to-manufacturer prescription programs to support self-insured employee health plans and state agencies outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities including Oregon, requiring manufacturer pricing compliance with Drug Supply Chain Security Act standards and authorized wholesaler distribution through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with a two-year contract term and 3 percent administrative fees.